Alignment Healthcare, Inc. (ALHC)
| Market Cap | 3.74B +30.6% |
| Revenue (ttm) | 4.26B +41.8% |
| Net Income | 19.81M |
| EPS | 0.10 |
| Shares Out | 206.73M |
| PE Ratio | 187.24 |
| Forward PE | 33.71 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,772,294 |
| Open | 15.24 |
| Previous Close | 15.35 |
| Day's Range | 15.24 - 18.18 |
| 52-Week Range | 11.63 - 23.87 |
| Beta | 1.15 |
| Analysts | Strong Buy |
| Price Target | 24.92 (+37.6%) |
| Earnings Date | Jul 29, 2026 |
About ALHC
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Financial Performance
In 2025, Alignment Healthcare's revenue was $3.95 billion, an increase of 46.06% compared to the previous year's $2.70 billion. Losses were -$724,000, -99.43% less than in 2024.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for ALHC stock is "Strong Buy." The 12-month stock price target is $24.92, which is an increase of 37.60% from the latest price.
News
Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
The company rises 196 spots to No. 791 on the Fortune 1000 2026 list following continued growth and momentum The company rises 196 spots to No. 791 on the Fortune 1000 2026 list following continued gr...
Alignment Healthcare exec buys $197.6K in common stock
In a regulatory filing, Alignment Healthcare (ALHC) President Mark Kent bought 14.8K shares of common stock on June 2 in a total transaction size of $197.6K.
Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report
Fifth annual report introduces refreshed impact strategy, aligned with long-term, responsible growth Fifth annual report introduces refreshed impact strategy, aligned with long-term, responsible growt...
Alignment Healthcare price target lowered to $16 from $19 at Barclays
Barclays lowered the firm’s price target on Alignment Healthcare (ALHC) to $16 from $19 and keeps an Equal Weight rating on the shares. The firm believes the managed care stock…
Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
ORANGE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in M...
Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality
Pharmacy Quality Alliance award underscores sustained excellence in care delivery, medication adherence and pharmacy excellence for seniors Pharmacy Quality Alliance award underscores sustained excell...
Alignment Healthcare Transcript: Bank of America Global Healthcare Conference 2026
Strong financial performance and stable trends are supported by advanced data analytics and operational discipline. Expansion outside California is accelerating, with higher margin potential and direct provider engagement. AI and technology investments are expected to further enhance efficiency and competitive positioning.
Alignment Healthcare CEO Adds Chairman Role As Medicare Business Grows
Alignment Healthcare is bolstering its management team, adding the chairman's role to top executive and founder John Kao's duties while promoting several other executives as the company sells more Med...
Alignment Healthcare names CEO John Kao chairman, Shane Hochradel COO
Alignment Healthcare (ALHC) announced leadership updates. Founder and CEO John Kao has been named chairman of the board, in addition to his role as CEO. Kao will continue to lead…
Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation
Founder and CEO John Kao Assumes Additional Role as Chairman of the Board Founder and CEO John Kao Assumes Additional Role as Chairman of the Board
Alignment Healthcare Proxy statement: Proxy filing
Alignment Healthcare filed a proxy statement on May 12, 2026, providing details for shareholder voting and corporate governance matters.
Alignment Healthcare to replace Sun Country Airlines in S&P 600 at open on 5/14
Alignment Healthcare (ALHC) will replace Sun Country Airlines Holdings (SNCY) in the S&P SmallCap 600 effective prior to the opening of trading on May 14. S&P SmallCap 600 constituent Allegiant…
Alignment Healthcare Set to Join S&P SmallCap 600
NEW YORK, May 11, 2026 /PRNewswire/ -- Alignment Healthcare Inc. (NASD: ALHC) will replace Sun Country Airlines Holdings Inc. (NASD: SNCY) in the S&P SmallCap 600 effective prior to the opening of tra...
Alignment Healthcare price target lowered to $22 from $27 at Raymond James
Raymond James lowered the firm’s price target on Alignment Healthcare (ALHC) to $22 from $27 and keeps a Strong Buy rating on the shares. The stock has been under pressure…
Alignment Healthcare price target raised to $22 from $21 at UBS
UBS analyst Jonathan Yong raised the firm’s price target on Alignment Healthcare (ALHC) to $22 from $21 and keeps a Neutral rating on the shares.
Alignment Healthcare price target raised to $19 from $18 at Barclays
Barclays raised the firm’s price target on Alignment Healthcare (ALHC) to $19 from $18 and keeps an Equal Weight rating on the shares.
Alignment Healthcare Earnings Call Transcript: Q1 2026
Membership and revenue grew over 30% year-over-year, with adjusted EBITDA up 88% and margin expansion driven by operational improvements and automation. Guidance for 2026 was raised, and the company is investing in AI and considering in-house supplemental benefits to further enhance profitability.
Alignment Healthcare Earnings release: Q1 2026
Alignment Healthcare released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Alignment Healthcare Quarterly report: Q1 2026
Alignment Healthcare has published its Q1 2026 quarterly earnings report on April 30, 2026.
Alignment Healthcare reports Q1 EPS 5c, consensus 9c
Reports Q1 revenue $1.23B, consensus $1.22B. “Our first-quarter performance demonstrates that Alignment continues to grow with discipline,” said John Kao, founder and CEO. “We expanded our profitabili...
Alignment Healthcare sees Q2 revenue $1.3B-$1.32B, consensus $1.31B
Sees Q2 adjusted EBITDA $50M-$60M.
Alignment Healthcare Turns A Profit As Medicare Advantage Costs Ease
Alignment Healthcare Thursday reported net income of more than $11 million as costs of care for older adults in its Medicare Advantage plans eased amid industry struggles with high medical expenses.
Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion
ORANGE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its first quarter ended March 31, 2026.
Alignment Healthcare (ALHC) Price Forecast: Bull Pennant Signals Breakout Potential
Alignment Healthcare approaches earnings with a bullish pennant pattern, rising momentum, and technical signals pointing toward a potential breakout toward prior highs.
Alignment Healthcare Proxy statement: Proxy filing
Alignment Healthcare filed a proxy statement on April 24, 2026, providing details for shareholder voting and corporate governance matters.